Home I Cardiovascular Conditions Insufficiency of mitral valve: Causes, Risk Factors, and How It Progresses

I Cardiovascular Conditions

Insufficiency of mitral valve: Causes, Risk Factors, and How It Progresses

January 17, 2026 Modified date: January 17, 2026

Mitral valve insufficiency—also called mitral regurgitation (blood leaks backward through the valve)—happens when the mitral valve doesn’t close tightly between the left atrium and left ventricle. Each heartbeat should send blood forward to the body. With a leak, some blood moves the wrong way, forcing the heart to pump extra volume just to keep up.

Many people feel fine for years, especially when the leak grows slowly. Others notice breathlessness on stairs, new fatigue, or a fluttering heartbeat that appears “out of nowhere.” The most important decisions are often about timing: when careful monitoring is enough, and when repairing the valve prevents permanent heart enlargement or rhythm problems.

This article explains what mitral valve insufficiency is, why it happens, who is at risk, which symptoms matter most, how doctors grade severity, what treatments help, and how to manage the condition long term.

What mitral valve insufficiency does to the heart
Causes and risk factors for mitral valve leakage
Symptoms, complications, and when it turns serious
How it’s diagnosed and how doctors grade severity
Treatment: medications, repair, replacement, and transcatheter options
Management, follow-up, prevention, and when to seek care

What mitral valve insufficiency does to the heart

The mitral valve is a one-way door between the left atrium (the chamber that receives oxygen-rich blood from the lungs) and the left ventricle (the main pumping chamber). In mitral valve insufficiency, the valve doesn’t seal fully during ventricular contraction. As a result, part of the blood that should go forward into the aorta leaks backward into the left atrium.

Why a “leak” can be quiet at first

When regurgitation develops slowly, the heart adapts. The left atrium enlarges to handle extra volume, and the left ventricle often becomes slightly bigger to maintain forward output. This compensation can work for years. The catch is that compensation can mask progression until the heart begins to struggle—often seen as rising pressures in the lungs, worsening shortness of breath, or new rhythm problems.

Primary vs secondary mitral regurgitation

Clinicians separate mitral insufficiency into two practical categories because treatment strategy differs:

Primary (degenerative) mitral regurgitation: the valve apparatus is the main problem—leaflets, chordae (string-like supports), or valve ring. A classic example is mitral valve prolapse with a flail leaflet.
Secondary (functional) mitral regurgitation: the valve may be structurally normal, but the ventricle is enlarged or weakened (often from coronary disease or cardiomyopathy), pulling the valve open so it can’t close properly.

This distinction matters because primary disease is often best treated by valve repair when severe, while secondary disease often starts with optimizing heart failure therapy and considering procedures selectively.

What happens downstream: lungs and rhythm

When the left atrium faces repeated volume overload, pressure can transmit backward into lung vessels, leading to breathlessness and pulmonary hypertension. Over time, atrial enlargement increases the risk of atrial fibrillation (a rapid, irregular rhythm). Atrial fibrillation can reduce exercise tolerance, raise stroke risk, and accelerate symptoms—sometimes becoming the first obvious sign that the valve leak has become significant.

Causes and risk factors for mitral valve leakage

Mitral valve insufficiency has many causes, but most fall into “structural valve problems” or “heart muscle/shape problems.” Knowing which bucket a person fits into helps clinicians predict progression and choose the most effective treatment path.

Common causes of primary (structural) mitral insufficiency

Mitral valve prolapse (degenerative disease): leaflets become redundant or weakened and may billow backward. If supporting chords rupture, the leak can worsen suddenly.
Myxomatous degeneration: a tissue change that makes leaflets thick and floppy over time.
Infective endocarditis: infection can destroy leaflet edges or chordae, causing acute severe leakage.
Rheumatic heart disease: scarring can deform leaflets and restrict closure.
Congenital valve abnormalities: less common, but present from birth.

Risk factors that often travel with degenerative disease include family history, connective tissue disorders, and age-related tissue changes.

Common causes of secondary (functional) mitral insufficiency

Heart attack or ischemic heart disease: changes in ventricular shape or papillary muscle function can prevent tight closure.
Dilated cardiomyopathy: an enlarged ventricle pulls the valve ring apart.
Long-standing high blood pressure: can contribute to remodeling that worsens leakage.
Atrial functional mitral regurgitation: in some people, a very enlarged left atrium (often from long-standing atrial fibrillation) stretches the valve ring and causes leakage even with relatively preserved ventricle function.

Risk factors that increase likelihood or worsen progression

High blood pressure
Diabetes and metabolic syndrome
Smoking (via effects on vascular disease and heart remodeling)
Obesity and obstructive sleep apnea (both linked to atrial enlargement and atrial fibrillation)
Prior heart attack or established coronary artery disease
Chronic kidney disease
Older age

Triggers for sudden worsening

Even stable mitral regurgitation can change quickly. Common “turning points” include:

Chordal rupture in mitral valve prolapse (often sudden breathlessness)
New atrial fibrillation (palpitations, fatigue, reduced stamina)
Endocarditis (fever plus new or worsening murmur)
Worsening heart failure or new ischemia

A useful, practical insight: if symptoms change abruptly, clinicians often suspect a mechanical shift—like chordal rupture or a new rhythm problem—rather than a slow natural progression.

Symptoms, complications, and when it turns serious

Symptoms depend on how severe the leak is, how quickly it developed, and how well the heart has adapted. People with chronic disease often subconsciously reduce activity to avoid symptoms, so the condition can look “stable” until something forces the issue—an infection, a new rhythm, or a busy week that demands more exertion.

Common symptoms

Shortness of breath with exertion (stairs, hills, brisk walking)
Fatigue or reduced stamina
Waking up short of breath or needing extra pillows
Palpitations or irregular heartbeat sensations
Cough, especially at night, or a feeling of chest congestion
Swelling in ankles or legs in later stages

In acute severe mitral regurgitation (for example, from chordal rupture or endocarditis), breathlessness can be sudden and intense, sometimes with frothy sputum from pulmonary edema.

Complications clinicians try to prevent

Atrial fibrillation: enlarged atrium increases risk; atrial fibrillation increases stroke risk and can worsen symptoms.
Pulmonary hypertension: chronic high pressure in lung vessels can become harder to reverse.
Heart failure: the ventricle may eventually weaken from chronic volume overload or underlying cardiomyopathy.
Right-sided heart strain: long-standing lung pressure elevation can strain the right ventricle.
Endocarditis risk: risk depends on valve anatomy and prior infections; prompt evaluation of persistent fever matters.

How clinicians judge seriousness beyond symptoms

Because symptoms can lag behind heart damage, doctors rely heavily on imaging indicators, such as:

Enlargement of the left ventricle or left atrium beyond expected ranges
Declining pumping function (even a “normal-looking” number may be concerning in MR, because forward output can be lower than it appears)
Rising estimated pressures in the lungs
New atrial fibrillation

Warning signs that should prompt urgent evaluation

Seek urgent or emergency care for:

Sudden severe shortness of breath at rest
Chest pain with faintness, sweating, or severe weakness
New neurologic symptoms (face droop, arm weakness, trouble speaking)
Rapid, sustained palpitations with dizziness or near-fainting
Fever with a new heart murmur, or fever plus worsening breathlessness (possible endocarditis)

A helpful personal rule is: if you notice a clear drop in your “baseline” over weeks—like needing to stop on stairs you used to climb easily—contact your clinician promptly. Early adjustment or timely referral can prevent irreversible heart changes.

How it’s diagnosed and how doctors grade severity

Diagnosis focuses on confirming mitral regurgitation, identifying its mechanism (primary vs secondary), and measuring how much it affects the heart and lungs. The most important tool is echocardiography, but clinicians often add other tests to build a complete risk picture.

Echocardiogram: the central test

A transthoracic echocardiogram (standard ultrasound on the chest) can:

Show the regurgitant jet and estimate severity
Identify leaflet prolapse, flail segments, or restricted motion
Measure left atrial size and left ventricular size
Estimate pumping function and lung pressures
Evaluate other valves and overall cardiac structure

Clinicians grade severity using multiple parameters (rather than a single number), and they also track trends over time—how quickly chamber sizes change can be as important as the current snapshot.

Transesophageal echo for detail

A transesophageal echocardiogram (TEE) places an ultrasound probe in the esophagus to obtain sharper images. It is commonly used when:

The mechanism needs precise definition for repair planning
Endocarditis is suspected
The standard echo images are limited
A transcatheter procedure is being considered

Other tests that refine decisions

Depending on symptoms and the clinical question, clinicians may use:

ECG and rhythm monitoring to detect atrial fibrillation or other arrhythmias
Exercise testing to reveal symptoms a person has adapted around
Cardiac MRI when quantifying regurgitation or ventricular volumes is difficult on echo
Coronary evaluation (stress imaging or angiography) when ischemia may be contributing, especially in secondary MR
Blood tests to evaluate anemia, thyroid disease, kidney function, and markers of congestion

Why “normal ejection fraction” can be misleading

In mitral regurgitation, the ventricle may eject blood both forward (useful) and backward (wasted). That can make ejection fraction look preserved even when effective forward flow is falling. Clinicians therefore pay close attention to:

Left ventricular end-systolic size
Changes in ejection fraction over time
Symptom patterns and exercise capacity
Pulmonary pressures and atrial size

What a good diagnostic visit accomplishes

By the end of an ideal evaluation, you should know:

The likely cause (degenerative, ischemic, dilated cardiomyopathy, atrial-related)
Whether the leak is mild, moderate, or severe
Whether the heart is still compensating well
What the follow-up interval should be
Which findings would trigger referral for intervention

Treatment: medications, repair, replacement, and transcatheter options

Treatment depends on the type of mitral regurgitation, severity, symptoms, and heart response. In general, medications manage consequences; repair or replacement fixes the leak. The best outcomes come from matching the treatment to the mechanism and timing intervention before the heart loses resilience.

Medications: symptom relief and heart protection

Medications cannot “tighten” a structurally abnormal valve, but they can reduce pressure, congestion, and rhythm-related symptoms. Depending on the situation, clinicians may use:

Diuretics to reduce fluid overload and breathlessness
Blood pressure medications to reduce afterload and heart workload
Heart failure therapies for secondary MR (often central to improvement)
Rate or rhythm control medications for atrial fibrillation
Anticoagulation when atrial fibrillation or other stroke-risk factors are present

In secondary MR, optimizing guideline-directed heart failure therapy can substantially reduce regurgitation in some patients by improving ventricular shape and function.

Mitral valve repair: often preferred in primary disease

For severe primary mitral regurgitation, repair is often favored over replacement when feasible because it can preserve heart function and avoid certain long-term issues associated with prosthetic valves. Repair success depends on valve anatomy and surgical expertise. High-volume valve repair centers often achieve better durability, so referral choice can matter.

Mitral valve replacement: when repair is not feasible

Replacement may be recommended when valve tissue is too damaged or distorted for durable repair (for example, extensive rheumatic scarring or complex endocarditis destruction). Valve choice (mechanical vs tissue) depends on age, bleeding risk, preference, and the ability to take long-term anticoagulation.

Transcatheter options for selected patients

For people who are high-risk for surgery or have secondary MR despite optimized medical therapy, transcatheter edge-to-edge repair (often referred to by device-based approaches) may reduce symptoms and hospitalizations in selected populations. Patient selection is crucial; the benefit depends on the balance between valve leakage severity and the underlying ventricular disease.

Some centers also offer transcatheter mitral valve replacement in specialized contexts, but availability and suitability depend on anatomy and local expertise.

Timing: the decision that protects the heart

Intervention is often considered when severe MR is present and any of the following occur:

Symptoms attributable to MR
Declining ventricular function or enlarging ventricular size
New atrial fibrillation
Rising pulmonary pressures

The goal is to act before the heart becomes permanently enlarged or weakened. Waiting until symptoms are dramatic can reduce the chance of full recovery after repair.

Management, follow-up, prevention, and when to seek care

Long-term management combines structured monitoring with a daily plan that protects the heart and reduces avoidable triggers. Many people live active lives with mild or moderate MR, and even severe MR can be managed safely when follow-up is consistent and intervention is timed well.

Follow-up schedules and what they track

Your clinician will tailor follow-up to severity and mechanism, but common patterns include:

Mild MR: periodic echo every few years
Moderate MR: echo every 1–2 years
Severe MR: echo every 6–12 months (or sooner if symptoms change)

Between visits, clinicians watch:

Left ventricular size and pumping strength
Left atrial size and rhythm stability
Estimated lung pressures
The mechanism of MR (prolapse progression, ventricular remodeling, ring dilation)

Exercise, activity, and symptom pacing

Most people benefit from steady aerobic activity. Practical approaches:

Choose moderate, repeatable effort rather than “all-out” bursts
Build up gradually, especially if you’ve reduced activity due to symptoms
If you have significant MR or pulmonary hypertension, get individualized guidance about heavy lifting and high-intensity exertion

Cardiac rehabilitation can be especially helpful when MR coexists with heart failure, coronary disease, or deconditioning.

Preventing endocarditis and managing infections

Excellent oral hygiene and prompt evaluation of persistent fever matter, especially if you have a history of valve infection or a repaired/replaced valve. Not everyone needs antibiotics before dental procedures; recommendations depend on specific risk categories. Ask your clinician for a clear, personalized rule so you’re not guessing.

Living with atrial fibrillation risk

Because atrial fibrillation is a common turning point, it helps to know early signs:

New irregular pulse
Palpitations plus reduced stamina
Breathlessness that is new or disproportionate

Early detection allows earlier rhythm or rate strategies and stroke prevention decisions.

When to seek urgent or emergency care

Seek emergency care for:

Sudden severe shortness of breath or pink frothy sputum
Chest pain with faintness, sweating, or severe weakness
Stroke-like symptoms (face droop, arm weakness, speech trouble)
Rapid palpitations with dizziness or fainting

Contact your clinician promptly for:

A noticeable decline in exercise tolerance over weeks
More frequent nighttime breathlessness or swelling
Increasing need for diuretics or nitroglycerin (if prescribed for coexisting disease)
Fever with new or worsening shortness of breath

The best long-term outcomes usually come from three habits: keep imaging on schedule, treat blood pressure and rhythm issues early, and choose intervention timing based on objective heart changes—not only on how “tough” you can push through symptoms.

References

Disclaimer

This article is for educational purposes and does not replace individualized medical advice, diagnosis, or treatment from a licensed clinician. Mitral valve insufficiency can be stable for years or progress silently; decisions about monitoring, medications, rhythm management, and the timing and type of valve intervention depend on symptoms, echocardiogram findings, heart size and function, lung pressures, and other health conditions. Seek emergency care immediately for sudden severe shortness of breath, chest pain at rest, fainting, stroke-like symptoms, or rapid irregular heartbeat with dizziness. Never start, stop, or change heart medications—including blood thinners—without guidance from your healthcare team.

If you found this article helpful, please share it on Facebook, X (formerly Twitter), or any platform you prefer, and follow us on social media. Your support through sharing helps our team continue producing high-quality, trustworthy health content.

Table of Contents